In these cancers, DSCAM‐AS1 modulates the expression of FOXA1 and ERα by interacting with YBX1, influencing YBX1 recruitment to the promoter regions of FOXA1 and Erα and thereby promoting tumour progression [51]. Here, DSCAM-AS1 is linked to cancer.